SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Addiction Medicine Consultation — Calamity Jane

PatientMartha Canary
Date of birth1981-05-01
IdentifiersMRN HR-NI008-SYN; SSN (made up) 000-08-9532
Document date2026-03-09
AuthorDolores Two Bulls-Harmon, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Severe alcohol use disorder in a 44-year-old woman without stable housing, starting outpatient withdrawal management today. Please confirm the diagnosis, review the withdrawal plan and advise on a medicine for alcohol use disorder, her liver, her mood and recovery support. [S]

Urgency: Within one week, on the same day as her one-week primary care visit. [S]

Questions for the consultant:

History of Present Illness

Ms. Canary, a 44-year-old woman who does odd jobs and moves between towns, is seen at the request of Dr. Kessler one week after starting outpatient withdrawal management. She has drunk heavily for most of her adult life and has tried to stop many times on her own. Her last drink was a week ago. With gabapentin, thiamine and daily nurse checks, her withdrawal peaked at a CIWA-Ar of 10 on the second day and is now over. She wants to stop drinking altogether, does not want to be lectured, and would rather not take a pill every day if there is another way. She has a friend who supports her and has met the clinic's peer recovery specialist. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Gabapentin 300 mg oral capsule on a written five-day schedule for alcohol withdrawal: 300 mg in the morning, 300 mg in the afternoon and 600 mg at bedtime for three days, then 300 mg twice daily on day four, 300 mg at bedtime on day five, then stop; dispensed for the five days onlyPer the written five-day scheduleOral route2026-03-02 to 2026-03-06completedS
Thiamine 100 mg by intramuscular injection once daily for three days, given in the clinic100 mg intramuscularly once daily for three daysIntramuscular route2026-03-02 to 2026-03-04completedS
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-05activeS
Folic acid 1 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-02activeS
Potassium chloride extended-release 20 mEq oral tablet, one tablet daily with food for five daysOne tablet daily with food for five daysOral route2026-03-02 to 2026-03-06completedS
Magnesium oxide 400 mg oral tablet, one tablet twice daily for two weeksOne tablet twice daily for two weeksOral route2026-03-02 to 2026-03-16completedS
Naltrexone 50 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-09 to 2026-03-30completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Alcohol use disorder, severe (nine of eleven DSM-5-TR criteria), daily drinking of about a pint of whiskey with heavier binges for many years; synthetic modern episode linked to her documented lifelong heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding; DSM-5-TR severe alcohol use disorder maps to F10.20 when withdrawal is coded separately. Person-first language; not a claim about her real diagnosis.
Alcohol withdrawal, mild, at low risk of complications (PAWSS 3, CIWA-Ar 9 at intake; no past seizures or delirium tremens), managed as an outpatient with daily nurse checksresolvedconfirmed F10.230S — Synthetic withdrawal episode; resolved by the one-week visit.
Raised liver enzymes (AST 96, ALT 44, GGT 240 U/L) with a FIB-4 index of 3.93, above the cut point for possible advanced fibrosis; liver stiffness measurement plannedactiveconfirmed R74.01S — Synthetic presenting finding; superseded when elastography and the clinical picture supported alcohol-associated steatotic liver disease.
Depressive symptoms during heavy drinking (PHQ-9 14, item 9 scored 0); whether they are alcohol-induced or an independent depression to be judged after two to four weeks without alcoholactiveprovisional F32.AS — Synthetic provisional finding; resolved as the PHQ-9 fell to 5 after ten weeks without alcohol, consistent with alcohol-induced depressive symptoms. Not a claim about her real mood.
Daily chewing tobacco for many years; not ready to stop at intakeactiveconfirmed F17.220S — Synthetic modern coding anchored to the documented chewing tobacco.
Underweight (BMI 18.4) with poor food intake, low folate, magnesium and phosphate, and slightly low albuminactiveconfirmed R63.6S — Synthetic finding anchored to a contemporary impression of poor nutrition (R).
Housing instability: staying in a spare room at a friend's house, with nowhere to go if that ends; has stayed in shelters in past wintersactiveconfirmed Z59.811S — Synthetic social need anchored to her documented poverty and moves from town to town.
Food insecurity: often goes without meals at the end of the monthactiveconfirmed Z59.41S — Synthetic social need anchored to her documented poverty.

Physical Exam

Vital signs recorded on 2026-03-09; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralAlert; blood pressure 128/82, pulse 84
EyesNo nystagmus; no scleral icterus
NeurologicalNo tremor; gait steady; oriented
AbdomenSoft and non-tender; liver edge not palpable

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-09Potassium [Moles/volume] in Serum or Plasma3.9mmol/L3.5-5.1 mmol/LNormalS
2026-03-09Magnesium [Mass/volume] in Serum or Plasma1.8mg/dL1.7-2.3 mg/dLNormalS

Assessment

Data reviewed: Dr. Kessler's intake note and safety assessment; the nurse's daily CIWA-Ar scores (10 at most, 2 today). AUDIT 31, PEth 820 ng/mL, PHQ-9 14, GAD-7 11 and PC-PTSD-5 2 at intake. Intake laboratory results: AST 96, ALT 44 and GGT 240 U/L, albumin 3.4 g/dL, bilirubin 1.1 mg/dL, INR 1.0, platelets 162, MCV 103 fL; FIB-4 3.93. Today potassium 3.9 mmol/L and magnesium 1.8 mg/dL after replacement. HIV and hepatitis C negative; hepatitis B not infected and not immune; urine drug test negative for opioids, fentanyl and other drugs; pregnancy test negative. [S]

Plan of Treatment